Consolidated Balance Sheets (USD $) In Thousands, unless otherwise specified	Jul. 31, 2013	Apr. 30, 2013
Current Assets:
Cash and cash equivalents	$ 4,408	$ 5,811
Restricted cash	619	691
Receivables, less allowance	24,752	25,884
Inventories	12,334	13,203
Deferred income taxes	607	654
Prepaid expenses and other current assets	1,469	987
Total Current Assets	44,189	47,230
Property, plant and equipment, at cost	45,627	45,109
Accumulated depreciation	(30,632)	(30,011)
Net Property, Plant and Equipment	14,995	15,098
Deferred income taxes	2,323	2,241
Other	4,352	4,173
Total Other Assets	6,675	6,414
Total Assets	65,859	68,742
Current Liabilities:
Short-term borrowings and interest rate swap	5,101	6,997
Current portion of long-term debt	455	200
Accounts payable	8,234	10,406
Employee compensation and amounts withheld	1,861	2,076
Deferred revenue	648	488
Other accrued expenses	3,117	1,948
Total Current Liabilities	19,416	22,115
Long-term debt	4,508	3,267
Accrued pension and deferred compensation costs	10,037	9,667
Other non-current liabilities	888
Total Liabilities	34,849	35,049
Commitments and Contingencies
Equity:
Common Stock	6,550	6,550
Additional paid-in-capital	1,619	1,567
Retained earnings	30,644	31,191
Accumulated other comprehensive loss	(7,786)	(7,327)
Common stock in treasury, at cost	(241)	(305)
Total Kewaunee Scientific Corporation Stockholders' Equity	30,786	31,676
Noncontrolling interest	224	2,017
Total Equity	31,010	33,693
Total Liabilities and Equity	$ 65,859	$ 68,742